Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 166

1.

Fast, volumetric live-cell imaging using high-resolution light-field microscopy.

Li H, Guo C, Kim-Holzapfel D, Li W, Altshuller Y, Schroeder B, Liu W, Meng Y, French JB, Takamaru KI, Frohman MA, Jia S.

Biomed Opt Express. 2018 Dec 4;10(1):29-49. doi: 10.1364/BOE.10.000029. eCollection 2019 Jan 1.

2.

Oxidized LDL phagocytosis during foam cell formation in atherosclerotic plaques relies on a PLD2-CD36 functional interdependence.

Ganesan R, Henkels KM, Wrenshall LE, Kanaho Y, Di Paolo G, Frohman MA, Gomez-Cambronero J.

J Leukoc Biol. 2018 May;103(5):867-883. doi: 10.1002/JLB.2A1017-407RR. Epub 2018 Apr 14.

3.

Proliferative and metastatic roles for Phospholipase D in mouse models of cancer.

Roth E, Frohman MA.

Adv Biol Regul. 2018 Jan;67:134-140. doi: 10.1016/j.jbior.2017.11.004. Epub 2017 Nov 14. Review.

4.

Phospholipase D2 loss results in increased blood pressure via inhibition of the endothelial nitric oxide synthase pathway.

Nelson RK, Ya-Ping J, Gadbery J, Abedeen D, Sampson N, Lin RZ, Frohman MA.

Sci Rep. 2017 Aug 22;7(1):9112. doi: 10.1038/s41598-017-09852-4.

5.

Measuring Phospholipase D Enzymatic Activity Through Biochemical and Imaging Methods.

Philip F, Ha EE, Seeliger MA, Frohman MA.

Methods Enzymol. 2017;583:309-325. doi: 10.1016/bs.mie.2016.09.041. Epub 2016 Oct 22.

6.

Coincident Phosphatidic Acid Interaction Restrains Drp1 in Mitochondrial Division.

Adachi Y, Itoh K, Yamada T, Cerveny KL, Suzuki TL, Macdonald P, Frohman MA, Ramachandran R, Iijima M, Sesaki H.

Mol Cell. 2016 Sep 15;63(6):1034-43. doi: 10.1016/j.molcel.2016.08.013.

7.

The DNA Damage Transducer RNF8 Facilitates Cancer Chemoresistance and Progression through Twist Activation.

Lee HJ, Li CF, Ruan D, Powers S, Thompson PA, Frohman MA, Chan CH.

Mol Cell. 2016 Sep 15;63(6):1021-33. doi: 10.1016/j.molcel.2016.08.009. Epub 2016 Sep 8.

8.

Genetic and Stress-Induced Loss of NG2 Glia Triggers Emergence of Depressive-like Behaviors through Reduced Secretion of FGF2.

Birey F, Kloc M, Chavali M, Hussein I, Wilson M, Christoffel DJ, Chen T, Frohman MA, Robinson JK, Russo SJ, Maffei A, Aguirre A.

Neuron. 2015 Dec 2;88(5):941-956. doi: 10.1016/j.neuron.2015.10.046. Epub 2015 Nov 20.

9.

Physiological and pathophysiological roles for phospholipase D.

Nelson RK, Frohman MA.

J Lipid Res. 2015 Dec;56(12):2229-37. doi: 10.1194/jlr.R059220. Epub 2015 Apr 29. Review.

10.

Krüppel-like factor 6 regulates mitochondrial function in the kidney.

Mallipattu SK, Horne SJ, D'Agati V, Narla G, Liu R, Frohman MA, Dickman K, Chen EY, Ma'ayan A, Bialkowska AB, Ghaleb AM, Nandan MO, Jain MK, Daehn I, Chuang PY, Yang VW, He JC.

J Clin Invest. 2015 Mar 2;125(3):1347-61. doi: 10.1172/JCI77084. Epub 2015 Feb 17.

11.

The phospholipase D superfamily as therapeutic targets.

Frohman MA.

Trends Pharmacol Sci. 2015 Mar;36(3):137-44. doi: 10.1016/j.tips.2015.01.001. Epub 2015 Feb 3. Review.

12.

Role of mitochondrial lipids in guiding fission and fusion.

Frohman MA.

J Mol Med (Berl). 2015 Mar;93(3):263-9. doi: 10.1007/s00109-014-1237-z. Epub 2014 Dec 5. Review.

13.

Phospholipase D1 facilitates second-phase myoblast fusion and skeletal muscle regeneration.

Teng S, Stegner D, Chen Q, Hongu T, Hasegawa H, Chen L, Kanaho Y, Nieswandt B, Frohman MA, Huang P.

Mol Biol Cell. 2015 Feb 1;26(3):506-17. doi: 10.1091/mbc.E14-03-0802. Epub 2014 Nov 26.

14.

Aquaporin-3 re-expression induces differentiation in a phospholipase D2-dependent manner in aquaporin-3-knockout mouse keratinocytes.

Choudhary V, Olala LO, Qin H, Helwa I, Pan ZQ, Tsai YY, Frohman MA, Kaddour-Djebbar I, Bollag WB.

J Invest Dermatol. 2015 Feb;135(2):499-507. doi: 10.1038/jid.2014.412. Epub 2014 Sep 18.

15.

Trans-regulation of oligodendrocyte myelination by neurons through small GTPase Arf6-regulated secretion of fibroblast growth factor-2.

Akiyama M, Hasegawa H, Hongu T, Frohman MA, Harada A, Sakagami H, Kanaho Y.

Nat Commun. 2014 Aug 21;5:4744. doi: 10.1038/ncomms5744.

PMID:
25144208
16.

Cellular and physiological roles for phospholipase D1 in cancer.

Zhang Y, Frohman MA.

J Biol Chem. 2014 Aug 15;289(33):22567-74. doi: 10.1074/jbc.R114.576876. Epub 2014 Jul 2. Review.

17.

Phospholipase D activity underlies very-low-density lipoprotein (VLDL)-induced aldosterone production in adrenal glomerulosa cells.

Tsai YY, Rainey WE, Pan ZQ, Frohman MA, Choudhary V, Bollag WB.

Endocrinology. 2014 Sep;155(9):3550-60. doi: 10.1210/en.2014-1159. Epub 2014 Jun 23.

PMID:
24956203
18.

Regulation of mitochondrial morphology by lipids.

Ha EE, Frohman MA.

Biofactors. 2014 Jul-Aug;40(4):419-24. doi: 10.1002/biof.1169. Epub 2014 Apr 26. Review.

19.

Phosphatidic acid (PA)-preferring phospholipase A1 regulates mitochondrial dynamics.

Baba T, Kashiwagi Y, Arimitsu N, Kogure T, Edo A, Maruyama T, Nakao K, Nakanishi H, Kinoshita M, Frohman MA, Yamamoto A, Tani K.

J Biol Chem. 2014 Apr 18;289(16):11497-511. doi: 10.1074/jbc.M113.531921. Epub 2014 Mar 5.

20.

IMGT/HighV QUEST paradigm for T cell receptor IMGT clonotype diversity and next generation repertoire immunoprofiling.

Li S, Lefranc MP, Miles JJ, Alamyar E, Giudicelli V, Duroux P, Freeman JD, Corbin VD, Scheerlinck JP, Frohman MA, Cameron PU, Plebanski M, Loveland B, Burrows SR, Papenfuss AT, Gowans EJ.

Nat Commun. 2013;4:2333. doi: 10.1038/ncomms3333.

21.

Pharmacological inhibition of phospholipase D protects mice from occlusive thrombus formation and ischemic stroke--brief report.

Stegner D, Thielmann I, Kraft P, Frohman MA, Stoll G, Nieswandt B.

Arterioscler Thromb Vasc Biol. 2013 Sep;33(9):2212-7. doi: 10.1161/ATVBAHA.113.302030. Epub 2013 Jul 18.

PMID:
23868933
22.

Deficiencies of the lipid-signaling enzymes phospholipase D1 and D2 alter cytoskeletal organization, macrophage phagocytosis, and cytokine-stimulated neutrophil recruitment.

Ali WH, Chen Q, Delgiorno KE, Su W, Hall JC, Hongu T, Tian H, Kanaho Y, Di Paolo G, Crawford HC, Frohman MA.

PLoS One. 2013;8(1):e55325. doi: 10.1371/journal.pone.0055325. Epub 2013 Jan 28.

23.
24.

Key roles for the lipid signaling enzyme phospholipase d1 in the tumor microenvironment during tumor angiogenesis and metastasis.

Chen Q, Hongu T, Sato T, Zhang Y, Ali W, Cavallo JA, van der Velden A, Tian H, Di Paolo G, Nieswandt B, Kanaho Y, Frohman MA.

Sci Signal. 2012 Nov 6;5(249):ra79. doi: 10.1126/scisignal.2003257.

25.

Mitochondria: signaling with phosphatidic acid.

Yang CY, Frohman MA.

Int J Biochem Cell Biol. 2012 Aug;44(8):1346-50. doi: 10.1016/j.biocel.2012.05.006. Epub 2012 May 15. Review.

26.

A role for phospholipase D3 in myotube formation.

Osisami M, Ali W, Frohman MA.

PLoS One. 2012;7(3):e33341. doi: 10.1371/journal.pone.0033341. Epub 2012 Mar 12.

27.

Visualizing mitochondrial lipids and fusion events in Mammalian cells.

Huang H, Frohman MA.

Methods Cell Biol. 2012;108:131-45. doi: 10.1016/B978-0-12-386487-1.00007-9. Review.

29.

Class III PI-3-kinase activates phospholipase D in an amino acid-sensing mTORC1 pathway.

Yoon MS, Du G, Backer JM, Frohman MA, Chen J.

J Cell Biol. 2011 Oct 31;195(3):435-47. doi: 10.1083/jcb.201107033. Epub 2011 Oct 24.

30.

OX1 orexin/hypocretin receptor activation of phospholipase D.

Jäntti MH, Putula J, Somerharju P, Frohman MA, Kukkonen JP.

Br J Pharmacol. 2012 Feb;165(4b):1109-23. doi: 10.1111/j.1476-5381.2011.01565.x.

31.

Mammalian phospholipase D physiological and pathological roles.

Peng X, Frohman MA.

Acta Physiol (Oxf). 2012 Feb;204(2):219-26. doi: 10.1111/j.1748-1716.2011.02298.x. Epub 2011 May 28. Review.

32.

piRNA-associated germline nuage formation and spermatogenesis require MitoPLD profusogenic mitochondrial-surface lipid signaling.

Huang H, Gao Q, Peng X, Choi SY, Sarma K, Ren H, Morris AJ, Frohman MA.

Dev Cell. 2011 Mar 15;20(3):376-87. doi: 10.1016/j.devcel.2011.01.004.

33.

Phosphatidylinositol-4-phosphate-5-kinase alpha deficiency alters dynamics of glucose-stimulated insulin release to improve glucohomeostasis and decrease obesity in mice.

Huang P, Yeku O, Zong H, Tsang P, Su W, Yu X, Teng S, Osisami M, Kanaho Y, Pessin JE, Frohman MA.

Diabetes. 2011 Feb;60(2):454-63. doi: 10.2337/db10-0614.

34.

The phospholipase D1 pathway modulates macroautophagy.

Dall'Armi C, Hurtado-Lorenzo A, Tian H, Morel E, Nezu A, Chan RB, Yu WH, Robinson KS, Yeku O, Small SA, Duff K, Frohman MA, Wenk MR, Yamamoto A, Di Paolo G.

Nat Commun. 2010;1:142. doi: 10.1038/ncomms1144.

35.

Rapid amplification of cDNA ends (RACE).

Yeku O, Frohman MA.

Methods Mol Biol. 2011;703:107-22. doi: 10.1007/978-1-59745-248-9_8.

PMID:
21125486
36.

Heterogeneity of phosphatidic acid levels and distribution at the plasma membrane in living cells as visualized by a Föster resonance energy transfer (FRET) biosensor.

Nishioka T, Frohman MA, Matsuda M, Kiyokawa E.

J Biol Chem. 2010 Nov 12;285(46):35979-87. doi: 10.1074/jbc.M110.153007. Epub 2010 Sep 8.

37.

Phospholipase D2-dependent inhibition of the nuclear hormone receptor PPARgamma by cyclic phosphatidic acid.

Tsukahara T, Tsukahara R, Fujiwara Y, Yue J, Cheng Y, Guo H, Bolen A, Zhang C, Balazs L, Re F, Du G, Frohman MA, Baker DL, Parrill AL, Uchiyama A, Kobayashi T, Murakami-Murofushi K, Tigyi G.

Mol Cell. 2010 Aug 13;39(3):421-32. doi: 10.1016/j.molcel.2010.07.022.

38.

Mitochondria as integrators of signal transduction and energy production in cardiac physiology and disease.

Frohman MA.

J Mol Med (Berl). 2010 Oct;88(10):967-70. doi: 10.1007/s00109-010-0662-x. Epub 2010 Aug 11. Review.

39.

A phosphatidic acid binding/nuclear localization motif determines lipin1 function in lipid metabolism and adipogenesis.

Ren H, Federico L, Huang H, Sunkara M, Drennan T, Frohman MA, Smyth SS, Morris AJ.

Mol Biol Cell. 2010 Sep 15;21(18):3171-81. doi: 10.1091/mbc.E10-01-0073. Epub 2010 Jul 21.

40.

A novel cell-free mitochondrial fusion assay amenable for high-throughput screenings of fusion modulators.

Schauss AC, Huang H, Choi SY, Xu L, Soubeyrand S, Bilodeau P, Zunino R, Rippstein P, Frohman MA, McBride HM.

BMC Biol. 2010 Jul 26;8:100. doi: 10.1186/1741-7007-8-100.

41.

A quantitative assay for mitochondrial fusion using Renilla luciferase complementation.

Huang H, Choi SY, Frohman MA.

Mitochondrion. 2010 Aug;10(5):559-66. doi: 10.1016/j.mito.2010.05.003. Epub 2010 May 19.

42.

Phosphatidic acid is a leukocyte chemoattractant that acts through S6 kinase signaling.

Frondorf K, Henkels KM, Frohman MA, Gomez-Cambronero J.

J Biol Chem. 2010 May 21;285(21):15837-47. doi: 10.1074/jbc.M109.070524. Epub 2010 Mar 19.

43.

Phospholipase D2 mediates acute aldosterone secretion in response to angiotensin II in adrenal glomerulosa cells.

Qin H, Frohman MA, Bollag WB.

Endocrinology. 2010 May;151(5):2162-70. doi: 10.1210/en.2009-1159. Epub 2010 Mar 10.

44.

Dependence of phospholipase D1 multi-monoubiquitination on its enzymatic activity and palmitoylation.

Yin H, Gui Y, Du G, Frohman MA, Zheng XL.

J Biol Chem. 2010 Apr 30;285(18):13580-8. doi: 10.1074/jbc.M109.046359. Epub 2010 Feb 26.

45.

Impaired alpha(IIb)beta(3) integrin activation and shear-dependent thrombus formation in mice lacking phospholipase D1.

Elvers M, Stegner D, Hagedorn I, Kleinschnitz C, Braun A, Kuijpers ME, Boesl M, Chen Q, Heemskerk JW, Stoll G, Frohman MA, Nieswandt B.

Sci Signal. 2010 Jan 5;3(103):ra1. doi: 10.1126/scisignal.2000551.

46.

Basis for the isoform-specific interaction of myosin phosphatase subunits protein phosphatase 1c beta and myosin phosphatase targeting subunit 1.

Scotto-Lavino E, Garcia-Diaz M, Du G, Frohman MA.

J Biol Chem. 2010 Feb 26;285(9):6419-24. doi: 10.1074/jbc.M109.074773. Epub 2009 Dec 30.

47.

Targeting phospholipase D with small-molecule inhibitors as a potential therapeutic approach for cancer metastasis.

Su W, Chen Q, Frohman MA.

Future Oncol. 2009 Nov;5(9):1477-86. doi: 10.2217/fon.09.110. Review.

48.

Cardiolipin synthesis is required to support human cholesterol biosynthesis from palmitate upon serum removal in Hela cells.

Hauff KD, Choi SY, Frohman MA, Hatch GM.

Can J Physiol Pharmacol. 2009 Oct;87(10):813-20. doi: 10.1139/Y09-055.

49.

Reversible bleb formation in mast cells stimulated with antigen is Ca2+/calmodulin-dependent and bleb size is regulated by ARF6.

Yanase Y, Carvou N, Frohman MA, Cockcroft S.

Biochem J. 2009 Dec 14;425(1):179-93. doi: 10.1042/BJ20091122.

PMID:
19845506
50.

Identification of alternative transcripts using rapid amplification of cDNA ends (RACE).

Yeku O, Scotto-Lavino E, Frohman MA.

Methods Mol Biol. 2009;590:279-94. doi: 10.1007/978-1-60327-378-7_18.

PMID:
19763511

Supplemental Content

Loading ...
Support Center